PROFIL
PELAJAR.COM
Nafenopin
References
Privacy Policy
My Blog
My Blog II
Profil Kampus
Prov. Aceh
Prov. Bali
Prov. Bangka Belitung
Prov. Banten
Prov. Bengkulu
Prov. D.I. Yogyakarta
Prov. D.K.I. Jakarta
Prov. Gorontalo
Prov. Jambi
Prov. Jawa Barat
Prov. Jawa Tengah
Prov. Jawa Timur
Prov. Kalimantan Barat
Prov. Kalimantan Selatan
Prov. Kalimantan Tengah
Prov. Kalimantan Timur
Prov. Kalimantan Utara
Prov. Kepulauan Riau
Prov. Lampung
Prov. Maluku
Prov. Maluku Utara
Prov. Nusa Tenggara Barat
Prov. Nusa Tenggara Timur
Prov. Papua
Prov. Papua Barat
Prov. Riau
Prov. Sulawesi Barat
Prov. Sulawesi Selatan
Prov. Sulawesi Tengah
Prov. Sulawesi Tenggara
Prov. Sulawesi Utara
Prov. Sumatera Barat
Prov. Sumatera Selatan
Prov. Sumatera Utara
Kidung Pujian
Digital Literasi
Zona Nonton
Campus Profile
School Profile
Keyword
Keyword 2
Share to:
Nafenopin
Nafenopin
Names
IUPAC name
2-Methyl-2-[4-(1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]propanoic acid
Other names
Nafenoic acid
Identifiers
CAS Number
3771-19-5
N
3D model (
JSmol
)
Interactive image
ChEBI
CHEBI:7449
N
ChEMBL
ChEMBL1909070
N
ChemSpider
18456
Y
KEGG
C11371
N
PubChem
CID
19592
UNII
093W78U96W
Y
CompTox Dashboard
(
EPA
)
DTXSID8020911
InChI
InChI=1S/C20H22O3/c1-20(2,19(21)22)23-16-12-10-15(11-13-16)18-9-5-7-14-6-3-4-8-17(14)18/h3-4,6,8,10-13,18H,5,7,9H2,1-2H3,(H,21,22)
Y
Key: XJGBDJOMWKAZJS-UHFFFAOYSA-N
Y
InChI=1S/C20H22O3/c1-20(2,19(21)22)23-16-12-10-15(11-13-16)18-9-5-7-14-6-3-4-8-17(14)18/h3-4,6,8,10-13,18H,5,7,9H2,1-2H3,(H,21,22)
InChI=1S/C20H22O3/c1-20(2,19(21)22)23-16-12-10-15(11-13-16)18-9-5-7-14-6-3-4-8-17(14)18/h3-4,6,8,10-13,18H,5,7,9H2,1-2H3,(H,21,22)
Key: XJGBDJOMWKAZJS-UHFFFAOYSA-N
SMILES
O=C(O)C(Oc1ccc(cc1)C3c2ccccc2CCC3)(C)C
Properties
Chemical formula
C
20
H
22
O
3
Molar mass
310.393
g·mol
−1
Except where otherwise noted, data are given for materials in their
standard state
(at 25 °C [77 °F], 100 kPa).
N
verify
(
what is
Y
N
?)
Infobox references
Chemical compound
Nafenopin
is a
hypolipidemic agent
.
[1]
References
^
Levine, W.G.; Meijer, D.K.F. (1977),
"THE CHOLERETIC EFFECT OF NAFENOPIN"
,
Abstracts
, Elsevier, p. 395
, retrieved
2022-12-21
v
t
e
Lipid-lowering agents
(
C10
)
GI tract
Cholesterol absorption inhibitors
,
NPC1L1
Ezetimibe
Hyzetimibe
SCH-48461
Bile acid sequestrants
/
resins
(
LDL
)
Colesevelam
Colestilan
Colestipol
Colestyramine
Colextran
Soluble fiber
such as
psyllium
and
glucomannan
Liver
Statins
(
HMG-CoA reductase
,
LDL
)
Atorvastatin
Cerivastatin
‡
Fluvastatin
Lovastatin
Mevastatin
Pitavastatin
Pravastatin
Rosuvastatin
Simvastatin
#
Niacin and derivatives (
HDL
and
LDL
)
Acipimox
Aluminium nicotinate
Niacin
Niceritrol
Nicofuranose
Nicotinyl alcohol
MTTP
inhibitors (
VLDL
)
Dirlotapide
Lomitapide
Mitratapide
ATP citrate lyase
inhibitors (
LDL
)
Bempedoic acid
Thyromimetics
(VLDL)
Dextrothyroxine
‡
Resmetirom
Blood vessels
PPAR agonists
(LDL)
Fibrates
Aluminium clofibrate
Bezafibrate
Choline fenofibrate
Ciprofibrate
Clinofibrate
Clofibrate
‡
Clofibride
Etofibrate
Fenofibrate
Gemfibrozil
Nafenopin
Pemafibrate
Ronifibrate
Simfibrate
Others
GW501516
§
CETP inhibitors
(
HDL
)
Anacetrapib
†
Dalcetrapib
§
Evacetrapib
§
Obicetrapib
†
Torcetrapib
§
PCSK9 inhibitors
(
LDL
)
Alirocumab
Bococizumab
Evolocumab
Inclisiran
ANGPTL3
inhibitors (
LDL
/
HDL
)
Evinacumab
Combinations
Amlodipine/atorvastatin
Bempedoic acid/ezetimibe
Ezetimibe/atorvastatin
Ezetimibe/rosuvastatin
Ezetimibe/simvastatin
Fenofibrate/pravastatin
Fenofibrate/simvastatin
Niacin/laropiprant
Niacin/lovastatin
Niacin/simvastatin
Other
Alipogene tiparvovec
Azacosterol
Azalanstat
Benfluorex
‡
Darapladib
§
Lapaquistat
§
Magnesium pyridoxal 5-phosphate glutamate
Meglutol
Mipomersen
Omega-3-triglycerides
Policosanol
Probucol
Tiadenol
Triparanol
‡
Volanesorsen
#
WHO-EM
‡
Withdrawn
from market
Clinical trials
:
†
Phase III
§
Never to phase III
Kembali kehalaman sebelumnya
Lokasi Pengunjung:
13.59.247.75